FDA clears updated COVID-19 vaccines for kids under age 5

日本 ニュース ニュース

FDA clears updated COVID-19 vaccines for kids under age 5
日本 最新ニュース,日本 見出し
  • 📰 sdut
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 95%

U.S. regulators have cleared doses of the updated COVID-19 vaccines to children younger than 5

U.S. regulators on Thursday cleared doses of the updated COVID-19 vaccines for children younger than age 5.

--Pfizer’s vaccine requires three initial doses for tots under age 5 -- and those who haven’t finished that vaccination series will get the original formula for the first two shots and the omicron-targeted version for their third shot. The Centers for Disease Control and Prevention is expected to sign off soon, the final step for shots to begin.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

sdut /  🏆 5. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

FDA authorizes updated COVID shots for kids as young as 6 months oldFDA authorizes updated COVID shots for kids as young as 6 months oldThe FDA is encouraging families to get young children vaccinated ahead of the holidays.
続きを読む »

FDA authorizes updated COVID-19 boosters for kids under 5FDA authorizes updated COVID-19 boosters for kids under 5The U.S. Food and Drug Administration authorized bivalent COVID-19 boosters for children between ages 6 months and 4 years Thursday.
続きを読む »

FDA clears updated COVID-19 vaccines for kids under age 5FDA clears updated COVID-19 vaccines for kids under age 5U.S. regulators have cleared doses of the updated COVID-19 vaccines to children younger than 5
続きを読む »

FDA authorizes Covid omicron vaccines for children as young as 6 months oldFDA authorizes Covid omicron vaccines for children as young as 6 months old
続きを読む »

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drugPfizer partners with Clear Creek Bio to develop oral COVID-19 drugPfizer Inc and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.
続きを読む »



Render Time: 2025-03-13 00:27:43